Molecular Classification
Other
Other Names
Blood-labyrinthine barrier, Blood-inner ear barrier
Disease Roles
Sensorineural hearing lossMeniere’s diseaseOtotoxicity

Blood-labyrinth barrier Overview

The **blood-labyrinth barrier** (BLB) is not a molecule or receptor, but rather a unique anatomical and physiological barrier system located in the inner ear, specifically in the **stria vascularis** and other cochlear regions[1][3][7]. The BLB is formed by **endothelial cells** joined by tight junctions, **pericytes**, a **basement membrane**, and **perivascular-resident macrophage-like melanocytes**. Its core function is to **limit and regulate the exchange of solutes, metabolites, and toxins between the bloodstream and the inner ear fluids (endolymph, perilymph)**[5][6][7]. It is equivalent in concept to the blood-brain barrier, but specifically maintains the composition and homeostasis of cochlear fluids necessary for hearing[1][3]. The barrier helps protect the ear from systemic toxins and supports essential functions like nutrient supply, ion absorption, and waste excretion[6][7]. BLB dysfunction is a pathological feature in conditions such as Meniere’s disease, sensorineural hearing loss, noise- and drug-induced hearing loss, and autoimmune diseases affecting the ear[2][3][7]. There is **no single molecular target, receptor, or gene designated as "BLB"**. The BLB is considered an *anatomical barrier* and *physiological entity*, not a druggable target like an enzyme or receptor[1][2][5][7]. Recent therapeutic research aims to exploit or traverse the BLB for targeted drug delivery, for example, nanoparticle-based therapies or agents capable of modulating BLB permeability[1][6][7]. However, there are **no drugs that interact directly with "the BLB" as a target**, and it is **not classified under molecular families like receptors, enzymes, or transporters**. **Note:** - This entry is **incorrect if used as a therapeutic molecular target** or if assigned as a classic receptor, enzyme, or transporter. - If you are seeking *molecular targets* within the BLB (like tight junction proteins, transporters, or signaling molecules), further specificity is required.

Mechanism of Action

Biological Functions

Maintenance of ionic homeostasis
Regulation of solute and metabolite exchange
Protection from toxins
Selective permeability
Fluid filtration

Disease Associations

Sensorineural hearing loss
Meniere’s disease
Ototoxicity
Noise-induced hearing loss
Autoimmune hearing loss
Age-related hearing loss

Safety Considerations

  • Barrier dysfunction may lead to elevated permeability, susceptibility to ototoxic drugs, inflammation, and hearing loss